TARGAXAN (rifaximin): Reviews and patient testimonials
Medication indications
TARGAXAN 550 mg film-coated tablets
TARGAXAN is indicated for the reduction in recurrence of episodes of overt hepatic encephalopathy in patients ≥ 18 years of age.
In the pivotal study, 91% of the patients were using concomitant lactulose.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Route of administration: Oral
Molecule: rifaximin
Patients' opinions on TARGAXAN
In brief
General satisfaction level: Be the first to evaluate
Treatment's effectiveness: Be the first to evaluate
Ease of use: Be the first to evaluate
Adherence to prescription: Be the first to evaluate
Detected side effects: Be the first to evaluate
Improvement in the quality of life: Be the first to evaluate
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.